LPL Financial
CORT icon

LPL Financial’s Corcept Therapeutics CORT Stock Holding History

LPL Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
139,389
+5,080
+4% +$307K ﹤0.01% 1962
2026
Q1 		$5.41M Buy
134,309
+99,582
+287% +$3.72M ﹤0.01% 2545
2025
Q4 		$1.21M Sell
34,727
-37,002
-52% -$2.91M ﹤0.01% 3880
2025
Q3 		$5.96M Buy
71,729
+2,086
+3% +$151K ﹤0.01% 2312
2025
Q2 		$5.11M Buy
69,643
+7,459
+12% +$541K ﹤0.01% 2288
2025
Q1 		$7.1M Buy
62,184
+1,502
+2% +$91.4K ﹤0.01% 1857
2024
Q4 		$3.06M Buy
60,682
+19,650
+48% +$1.03M ﹤0.01% 2486
2024
Q3 		$1.9M Sell
41,032
-23,307
-36% -$828K ﹤0.01% 2782
2024
Q2 		$2.09M Sell
64,339
-2,707
-4% -$74.2K ﹤0.01% 2558
2024
Q1 		$1.69M Buy
+67,046
New +$1.58M ﹤0.01% 2687
2023
Q2 		– Sell
-9,916
Closed -$215K – 4606
2023
Q1 		$215K Buy
+9,916
New +$217K ﹤0.01% 3990
2018
Q4 		– Sell
-10,579
Closed -$148K – 3103
2018
Q3 		$148K Sell
10,579
-5,143
-33% -$71.9K ﹤0.01% 3066
2018
Q2 		$247K Buy
+15,722
New +$274K ﹤0.01% 2822
2018
Q1 		– Sell
-10,833
Closed -$196K – 3198
2017
Q4 		$196K Sell
10,833
-40,425
-79% -$732K ﹤0.01% 2827
2017
Q3 		$989K Buy
+51,258
New +$764K ﹤0.01% 1437
2016
Q2 		– Sell
-105,000
Closed -$516K – 2679
2016
Q1 		$516K Buy
105,000
+76,000
+262% +$296K ﹤0.01% 2143
2015
Q4 		$135K Buy
+29,000
New +$131K ﹤0.01% 2931

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's CORT Position: Q2 2026 in Review

LPL Financial increased its Corcept Therapeutics (CORT) stake by 3.8% in Q2 2026, buying an estimated $307K and bringing the position to 139,389 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

LPL Financial first reported a position in CORT in Q4 2015 and has held it in 17 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • LPL Financial held 139,389 shares of Corcept Therapeutics worth $12.1M as of Q2 2026.
  • LPL Financial bought 5,080 Corcept Therapeutics shares in Q2 2026, an estimated $307K.
  • Corcept Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1962 holding.
  • LPL Financial first reported a position in Corcept Therapeutics in Q4 2015 and has held it in 17 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.